BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 868533)

  • 1. Effect of fibrinogen degradation products on the rat blood vessels.
    Buczko W
    Acta Physiol Pol; 1977; 28(2):153-9. PubMed ID: 868533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fibrinogen degradation products (FDP) on heart rate and some metabolic parameters in the rat.
    Buczko W
    Acta Physiol Pol; 1978; 29(3):259-66. PubMed ID: 707144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of fibrinogen degradation products (FDP) on the ATPase activity in the rat heart.
    Buczko W
    Acta Physiol Pol; 1978; 29(2):185-7. PubMed ID: 148831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fibrinogen degradation products on the action of amphetamine in the central nervous system.
    Zwoliński J; Buczko W
    Pol J Pharmacol Pharm; 1977; 29(3):313-9. PubMed ID: 560684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cyclic 3',5'-adenosine monophosphate and adenosine on vascular reactivity.
    Janiec W; Piekarska T; Grabowski J; Pałletko Z
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):797-805. PubMed ID: 206222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pressor action of propranolol; with special reference to relationship between the pressor action and peripheral vascular tone].
    Yamamoto J; Maekawa H; Sekiya A
    Nihon Yakurigaku Zasshi; 1976 Sep; 72(6):709-14. PubMed ID: 13028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fibrinogen degradation products (FDP) on the central action of acetylcholine.
    Zadrozna B; Buczko W
    Pol J Pharmacol Pharm; 1976; 28(6):679-84. PubMed ID: 1012988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reaction of peripheral veins and arteries following administration of beta-active agents. Studies on isoproterenol, propranolol, and practolol].
    Bischoff K; Larsen N; Mucha C; Westermann KW
    Med Klin; 1976 Jul; 71(30):1239-43. PubMed ID: 940512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats.
    Nakazawa T; Sato A; Mori A; Saito M; Sakamoto K; Nakahara T; Ishii K
    Vascul Pharmacol; 2008; 49(2-3):77-83. PubMed ID: 18585480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous control of venous tone--I: Effect of sympathetic chain stimulation on cutaneous capacitance and resistance vessels.
    Manchanda SK; Bhattarai R
    Indian J Physiol Pharmacol; 1974; 18(1):3-13. PubMed ID: 4412360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of alpha and beta adrenergic receptors blockade on the adrenolytic effect of muscular work.
    Janczewska H; Bogdański W; Trzebski A
    Acta Physiol Pol; 1980; 31(5):469-74. PubMed ID: 6263042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
    Guo F; Liu J; Wang C; Liu N; Lu P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of sympathomimetics and alpha- and beta-receptor blocking agents on the kidney function of rats].
    Heintze K; Heidenreich O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):137-8. PubMed ID: 4239176
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of phenoxybenzamine, propranolol, phenylephrine and isoproterenol on the circulation of rats bearing Guérin carcinoma.
    Debreczeni LA; Farsang C; Takács L
    Acta Physiol Acad Sci Hung; 1980; 56(4):341-65. PubMed ID: 7197111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.